Beyond Air (XAIR) Shareholder's Equity Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -54.92% |
| Sep 30, 2025 | -55.30% |
| Jun 30, 2025 | -41.19% |
| Mar 31, 2025 | -47.25% |
| Dec 31, 2024 | -21.69% |
| Sep 30, 2024 | 1.61% |
| Jun 30, 2024 | -54.78% |
| Mar 31, 2024 | -35.31% |
| Dec 31, 2023 | -57.66% |
| Sep 30, 2023 | -54.71% |
| Jun 30, 2023 | -45.14% |
| Mar 31, 2023 | -46.26% |
| Dec 31, 2022 | -38.92% |
| Sep 30, 2022 | 55.55% |
| Jun 30, 2022 | 113.31% |
| Mar 31, 2022 | 156.73% |
| Dec 31, 2021 | 427.43% |
| Sep 30, 2021 | 153.69% |
| Jun 30, 2021 | 83.38% |
| Mar 31, 2021 | 68.38% |
| Dec 31, 2020 | 43.22% |
| Sep 30, 2020 | 192.23% |
| Jun 30, 2020 | 132.07% |
| Mar 31, 2020 | 349.50% |
| Dec 31, 2019 | 389.29% |
| Sep 30, 2019 | 37.83% |
| Jun 30, 2019 | 40.77% |
| Mar 31, 2019 | 160.64% |
| Dec 31, 2018 | 129.31% |
| Sep 30, 2018 | 158.33% |
| Jun 30, 2018 | 3,070.10% |
| Mar 31, 2018 | 77.09% |
| Dec 31, 2017 | -78.30% |
| Dec 31, 2016 | -157.66% |